Interestingly, using immunohistochemistry, two groups have recently demonstrated that high CDK4 expression was associated with poor clinical outcome in NPC patients; including increased local and distant recurrence [21, 22]. The gene discussed is CDK4; the disease is nasopharyngeal carcinoma.